Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Larsen EH, Ålykkja A, Mellblom AV, Ruud E, Wahl AK, Lie HC(2025) The Development and Feasibility Testing of the Nurse-Led Transitioning Adolescents Off Cancer Treatment (TACT) Intervention J Adv Nurs(in press) DOI 10.1111/jan.16750, PubMed 39844508
O'Connell KS, Koromina M, van der Veen T, Boltz T, David FS, Yang JMK, Lin KH, Wang X, Coleman JRI, Mitchell BL, McGrouther CC, Rangan AV, Lind PA, Koch E, Harder A, Parker N, Bendl J, Adorjan K, Agerbo E, Albani D, Alemany S, Alliey-Rodriguez N, Als TD, Andlauer TFM, Antoniou Aet al.(2025) Genomics yields biological and phenotypic insights into bipolar disorder Nature(in press) DOI 10.1038/s41586-024-08468-9, PubMed 39843750
Fjærvoll KA, Fjærvoll HK, Yang M, Bair J, Utheim TP, Dartt DA(2025) Pyrimidinergic P2Y1-Like Nucleotide Receptors Are Functional in Rat Conjunctival Goblet Cells Invest Ophthalmol Vis Sci, 66(1), 46 DOI 10.1167/iovs.66.1.46, PubMed 39836405